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Abstract:  This  paper  describes  the  physiochemical,  optical  and  biological  activity  of 
chitosan-chromone derivative. The chitosan-chromone derivative gels were prepared by 
reacting chitosan with chromone-3-carbaldehyde, followed by solvent exchange, filtration 
and  drying  by  evaporation.  The  identity  of  Schiff  base  was  confirmed  by  UV-Vis 
absorption  spectroscopy  and  Fourier-transform  infrared  (FTIR)  spectroscopy.  The 
chitosan-chromone  derivative  was  evaluated  by  X-ray  diffraction  (XRD), 
thermogravimetric  analysis  (TGA),  differential  scanning  calorimetry  (DSC),  scanning 
electron microscopy (SEM), photoluminescence (PL) and circular dichroism (CD). The CD 
spectrum  showed  the  chitosan-chromone  derivative  had  a  secondary  helical  structure. 
Microbiological  screening  results  demonstrated  the  chitosan-chromone  derivative  had 
antimicrobial activity against Escherichia coli bacteria. The chitosan-chromone derivative 
did not have any adverse effect on the cellular proliferation of mouse embryonic fibroblasts 
(MEF)  and  did  not  lead  to  cellular  toxicity  in  MEFs.  These  results  suggest  that  the 
chitosan-chromone derivative gels may open a new perspective in biomedical applications. 
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1. Introduction 
Chitosan is an abundant heteropolysaccharide obtained from deacetylation of chitin, which is a 
polysaccharide  of  natural  origin  and  second  most  abundant  to  cellulose.  Considerable  interest  to 
OPEN ACCESS Int. J. Mol. Sci. 2012, 13  6103 
 
 
researchers lies in the biocompatible, biodegradable, cytocompatible, hemocompatible and adsorption 
properties of chitosan, which can be exploited to create unique building blocks with novel function via 
Schiff base [1–4]. These properties are attracting interest for use in pharmaceutical and biomedical 
fields,  including  as  antimicrobials,  gene  delivery,  carriers  of  immobilized  enzymes  and  cells, 
biosensors, artificial organs, and biodegradable packaging, as well as wound healing and as scaffolds 
for tissue regeneration [5–16]. Chitosan has a natural ability to bind metal ions. Misra et al. have 
reported a chitosan-grafted copolymer magnetic nanoparticle drug carrier for controlled drug release 
that responds to the change in external temperature or pH, with characteristics of longer circulation 
time and reduced side effects [17–19]. The heteropolysaccharide backbone of chitosan is structurally 
similar to  glycosaminoglycans,  the major component of the extracellular matrix of the bone [20]. 
Chitosan is also an osteoconductive [21] and hemostatic material [22,23]. The organic biopolymer 
containing chromophoric groups, whose optical property make the material much more important from 
a biotechnological and medicinal application point of view [24–26]. 
Chromones  (4H-chromone-4-ones)  are  heterocyclic  compounds  with  the  benzo-γ-pyrone 
framework. Chromones and their structural analogs are of great interest because of their usefulness as 
biologically active agents. They have been shown to be tyrosine and protein kinase inhibitors, as well 
as anticancer [27–30], neuroprotective [31], anti-AIDS [32–34], antimicrobial [35,36], antifungal [37], 
antioxidant  activity  [38],  interleukin-5  inhibitory  activity  [39],  and  antiproliferative  agents  [40]. 
Chromones may also have application in cystic fibrosis treatment, as they activate the cystic fibrosis 
transmembrane conductance regulator. Kumar et al. have reported a chromone analog inhibits TNF-α 
induced  expression  of  cell  adhesion  molecules  on  human  endothelial  cells  via  blocking  NF-κB 
activation [41]. Chromone derivatives may also be useful for other applications in medicinal chemistry, 
such as preparation of fluorescence probes, due to the photochemical properties of chromones. M. E. 
Badawy  [42]  reported  fungicidal  activity  of  the  N-(methyl-4H-chromene-4-one)  chitosan  against 
Pythium debaryanum and Fusarium oxysporum. 
Although  chromones  have  great  pharmaceutical  importance,  chitin  and  chitosan  are  cheaper 
biopolymers. As part of our continuing interest in chitosan modification [2,3,24,25,43], we became 
interested in preparation of chitosan-chromone derivative gels. There is no previous report on  the 
optical  properties  of  chitosan-chromone  derivative  gel  in  the  literatures.  In  this  paper,  we  report  
the  physiochemical,  optical  and  biological  activity  of  chitosan-chromone  derivative  gel  for  
biomedical applications. 
2. Results and Discussion 
The presence of free reactive amino groups leads to the possibility of forming a Schiff base of 
chitosan with chromone-3-carbaldehyde. The preparation of chitosan-chromone derivative is shown in 
Scheme 1. The hydrogel was subject to solvent exchange to remove water and resulting in the xerogel. 
UV-Vis and FTIR spectroscopy were used to confirm the structure of the Schiff base of chitosan. Int. J. Mol. Sci. 2012, 13  6104 
 
 
Scheme 1. Schematic representation of the preparation of chitosan-chromone derivative 
gel (Schiff base). 
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2.1. FTIR Spectra 
Figure 1a,b shows the FTIR spectra of chitosan and chitosan-chromone derivative, respectively. 
The pure chitosan spectrum in Figure 1a shows several characteristic peaks at 3360, 2919, 2874, 1640, 
1592,  1375,  1153,  1061  and  893  cm
−1  [44].  The  characteristic  peak’s  assignment  of  the  
chitosan-chromone derivative (Figure 1b) at 1660 cm
−1 is due to Schiff base (C=N) formed by a cross 
linking reaction between the amino group and the aldehydic group of chromone-3-carbaldehyde [45,46]. 
The C=O adsorption peak of secondary hydroxyl groups becomes stronger and moves to 1083 cm
−1; 
the intensity of primary alcohol 1034 cm
−1 due to C=O stretching vibration becomes much smaller than 
in pure chitosan. 3460 cm
−1 (O–H group of chitosan), 2924 and 2870 cm
−1 (C–H stretch), 1566 cm
−1 and 
(C=C stretch of aromatic ring) [47],
 of glucosamine residue. In the chitosan-chromone derivative, the 
peak at 1592 cm
−1 disappeared due to the loss of free amine indicating Schiff base amine functionality. 
Figure  1.  Fourier  transform  infrared  (FT-IR)  spectra  of  pure  chitosan  (a)  and  
chitosan-chromone derivative (b). 
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2.2. X-ray Diffraction (XRD) Study 
X-ray  diffraction studies  of pure  chitosan  exhibit  very broad peaks  at 2θ = 10°   and 2θ  = 20°   
(Figure 2a) [24]. The chitosan-chromone derivative displayed two weak peaks at around 2θ of 20°  and 
35°  (Figure 2b). However, the peak observed for chitosan at 2θ = 10°  disappeared and the very broad peak 
at 2θ = 20°  became weak in chitosan-chromone derivative. These results suggest that chitosan has good 
compatibility,  which  leads  to  the  formation  of  a  porous  xerogel  network.  The  XRD  pattern  also 
indicated that the chitosan-chromone derivative displays an amorphous form, which may participate in 
biomedical applications. 
Figure 2. X-ray Diffraction (XRD) pattern of pure chitosan (a) and chitosan-chromone derivative (b). 
 
2.3. Thermal Analysis (TGA, DSC) 
The TGA thermograms of pure chitosan and chitosan-chromone derivative are shown in Figure 3a,b. 
The TGA curve of pure chitosan shows that the two stages of weight loss is in the range from 47 to 
450 °C , the first occurring in the range of 47–100 °C  due to loss of water molecules with a weight loss 
of  about  9%.  The  primary  degradation  of  pure  chitosan  started  at  247  °C   and  it  was  completely 
degraded at about 450 °C  with a weight loss of about 34% [24]. TGA of chitosan-chromone derivative 
showed two different stages of weight loss (Figure 3b). The first stage of weight loss, starting from 29 
to 90 °C , may correspond to the loss of adsorbed water. The second decomposition stage occurs in the 
range  228–400  °C ,  due  to  thermal  degradation  with  a  weight  loss  of  about  54%.  The  results 
demonstrate the loss of the thermal stability for the chitosan-chromone derivative gel compared to  
the chitosan. 
The  DSC  thermogram  of  chitosan-chromone  derivative  is  presented  in  Figure  4.  The  DSC 
thermogram of chitosan (not shown) shows two broad endothermic peaks at 92 °C  and 212 °C . The 
first peak may be due to water vapor, while the latter may be attributed to the molecular arrangement Int. J. Mol. Sci. 2012, 13  6106 
 
 
of chitosan chains. DSC thermogram of chitosan-chromone derivative (Figure 4) showed characteristic 
sharp endothermic peaks at 85 °C  due to the loss of water molecules. There is one broad exothermic 
peak at 285 °C  corresponding to the thermal decomposition of chitosan-chromone derivative. The 
results indicated that the structure of chitosan chains have been changed due to the chromone ring and 
the reduced ability to crystallize. 
Figure 3. Thermogravimetric analysis (TGA) of pure chitosan (a) and chitosan-chromone 
derivative (b). 
 
Figure 4. Differential scanning calorimetry (DSC) of chitosan-chromone derivative. 
 
2.4. Scanning Electron Microscopy (SEM) 
The SEM images of the pure chitosan (Figure 5a,b) and chitosan-chromone derivative (Figure 5c,d) 
are shown in Figure 5. The SEM images of pure chitosan exhibited a nonporous, smooth membranous 
phase consisting of dome shaped orifices, microfibrils and crystallite. The electron micrographs of 
chitosan-chromone  derivative  gels  (Figure  5c,d)  exhibited  a  porous  and  chain-like  shape.  
Chitosan-chromone derivative gels also exhibited a cross-section of randomly oriented grains and also Int. J. Mol. Sci. 2012, 13  6107 
 
 
gave  an  image  of  the  upper  part  of  bread  slice.  The  SEM  image  also  confirmed  the  point  that  
the  chitosan-chromone  derivative  has  a  near  spherical  morphology,  which  may  participate  into  
biomedical applications. 
Figure 5. Scanning electron microscopy (SEM) images of pure chitosan (a) and (b), and 
chitosan-chromone derivative (c) and (d). 
 
2.5. Photoluminescence Properties (PL) 
Photoluminescence  spectra  are  powerful  tools  with  which  to  investigate  the  effect  of  the  
chitosan-chromone derivative on optical property. The emission spectra and fluorescent intensity of  
chitosan-chromone derivative are performed at their own excitation wavelength as shown in Figure 6. 
The emission spectra of chitosan-chromone derivative (λem) peak at 413 nm, 441 nm and 505 nm at 
excitation  wavelength  of  320  nm.  The  chitosan-chromone  derivative  showed  red-shifted  emission 
maximums due to the introduction of side chain and the electronic effect of the substituent on the side 
chain. This is because the attachment of the conjugate side group to the backbone will enlarge the 
degree of delocalized π-bond on the electron rich polymer main chain. The emission intensity was 
greatly influenced by the conjugation length and variation of the substituents. The p-π conjugated side 
chain can make the emission maximum of chitosan-chromone derivative red shift [24,25].
 The shifting 
wave number was decided by electronic effect. Int. J. Mol. Sci. 2012, 13  6108 
 
 
Figure  6.  Photoluminescence  (PL)  spectrum  of  chitosan-chromone  derivative  at  the 
excitation wavelength of 320 nm. 
 
2.6. UV-Vis Absorption Spectrum and Circular Dichroism (CD) Spectrum 
The  UV-vis  absorption  spectrum  of  the  chitosan-chromone  derivative  is  shown  in  Figure  7a.  
As shown in Figure 7a, the absorption peak of the chitosan-chromone derivative was 305 nm; this is 
due to the presence of the chromone heterocyclic ring. Chitosan itself is transparent in the UV-Vis 
region, and so its structure is hard to characterize by UV-Vis spectroscopic methods. However, we can 
overcome this natural handicap by borrowing chromophores from an extrinsic molecule. 
Figure 7. UV (a) and Circular dichroism (CD) (b) spectra of the chitosan-chromone derivative. 
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The investigation of the circular dichroism spectrum of the chitosan-chromone derivative is shown 
in Figure 7b at different time intervals. The spectrum in Figure 7b shows 0, 1 and 2 times in red, blue 
and green, respectively. A cotton effect in the CD spectrum in the range λ = 360 nm to 380 nm is 
characteristic for the helical structure of chitosan derivative and originates from the n-π
* transition of 
the helically arranged imine groups in the polymer backbone [48,49]. In the vicinity of absorption 
bands  of  the  chitosan  derivative,  which  shows  positive  or  negative  absorption,  curves  take  on  a 
characteristic  shape,  and  this  behavior  is  known  as  the  Cotton  effect.  The  CD  spectrum  of  
the chitosan-chromone derivative, showed no positive Cotton effect at λ = 370 nm, but instead a broad 
negative signal around λ = 370 nm with a decreased intensity (Figure 7b). The change in the circular 
dichroism spectrum could be the result of the prolonged time in solution leading to partial unfolding of 
the helical organization, in the presence of the chromone ring. 
2.7. Antimicrobial Study 
The  chitosan-chromone  derivative  had  a  dose-dependent  antimicrobial  activity  against  E.  coli 
showing CFUs of less than 2 ×  10
8 when present at a concentration of 0.1% (Figure 8). The most 
plausible reason for the antimicrobial character of the chitosan-chromone derivative is due to the fact 
that it has a positively charged amino group which can interacts with the negatively charged microbial 
cell  membranes  to  cause  the  leakage  of  intracellular  constituents  of  the  microorganisms,  thereby 
resulting in microbial death [44]. 
Figure  8.  Colony  forming  units  (CFU)  of  E.  coli  cultured  in  the  presence  of  
chitosan-chromone  derivative  at  a  concentration  of  0.1  (A),  0.01  (B),  0.001  (C)  or  
0.0001% (D). 
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2.8. Assay for Cellular Cytotoxicity, Proliferation, and Viability 
The presence of the chitosan-chromone derivative (0, 20, 40, 80, 120, 800 µg/mL) did not had any 
adverse affect (p > 0.05) on the cellular viability of mouse embryonic fibroblast (MEF) cells in culture, 
as measured by cytoplasmic esterase enzyme activity and plasma membrane integrity (Figure 9 and 
Table 1). The chitosan-chromone derivative treated cells also had a similar rate of growth as observed 
with  non-treated  control  cells  (Figure  10).  The  mean  population  doubling  time  (PDT)  and  rate  of 
proliferation per day (r) did not differ between non-treated control and chitosan-chromone derivative 
treated  cells  for  all  the  tested  concentrations  (Table  1;  p  >  0.05).  These  data  clearly  suggest  
that  the  chitosan-chromone  derivative  was  non-cytotoxic  and  had  no  adverse  effect  on  the  
cellular proliferation. 
Figure  9. Cellular viability of mouse embryonic fibroblast (MEF) cells cultured in the 
presence  of  0  (A),  40  (B),  80  (C),  or  800  µg/mL  (D)  chitosan-chromone  derivative. 
Viability was measure based on esterase enzyme activity and plasma membrane integrity 
by FDA (3',6'-diacetyl fluorescein diacetate) assay. Green fluorescence indicates viable cells. 
 
Figure 10. Cellular proliferation of mouse embryonic fibroblast (MEF) cells cultured in the 
presence of chitosan-chromone derivative at different concentrations as indicated (µ g/mL). 
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Table 1. Population doubling time (PDT), cell proliferation rate (r) and viability of mouse 
embryonic fibroblast (MEF) cells cultured in the absence or presence of chitosan-chromone 
derivative at different concentrations. 
Concentration (µg/mL)  PDT (h)  r/day  Viability (%) 
0  21.33 
a  0.81 
a  97.53 
a 
20  21.04 
a  0.82 
a  96.70 
a 
40  20.48 
a  0.85 
a  97.67 
a 
80  18.96 
a  0.93 
a  96.34 
a 
120  20.76 
a  0.84 
a  96.81 
a 
800  21.94 
a  0.78 
a  97.75 
a 
Three replicates were performed. Values with same superscript (a) within column did not differ 
significantly (p > 0.05). 
3. Experimental Section  
3.1. Synthesis of 4-oxo-4H-Chromene-3-Carbaldehyde 
POCl3  (6  mol)  was  added  drop  wise  to  2-hydroxy  acetophenone  in  50  mL  DMF  (1  mol)  for  
15 min at 0 °C . After, the reaction was allowed to stand at room temperature overnight. Reaction 
mixture was quenched with water and extracted with ethyl acetate. The resulting organic layer was 
washed  with  brine,  dried  over  Na2SO4  and  concentrated  under  reduced  pressure  to  give  a  pure 
compound.  The  yield  82%,  a  yellow  solid,  was  obtained  according  to  the  procedure  described 
elsewhere [50]. 
3.2. Preparation of Chitosan-Chromone Derivative 
For the preparation of the chitosan-chromone derivative, 500 mg of chitosan powder was dissolved 
in 25 mL of 1.5% (v/v) glacial acetic acid. The mixture was vigorously stirred by a magnet stirrer at 
room temperature until the polymer was completely dissolved. 100 mg of chromone-3-carbaldehyde in 
ethanol solution was added drop wise into the chitosan solution and stirred at room temperature for 4 h. 
The prepared hydrogel solution was then subjected to solvent exchange into acetone (3 ×  50 mL) at 
room temperature. After that, the product was filtered by vacuum. The final product was dried by 
evaporation at room temperature. 
3.3. Characterization Methods 
Fourier transform infrared (FT-IR) spectra were recorded on a JASCO FT-IR 300E device using 
KBr. XRD patterns of the samples were recorded on an X-ray diffractometer (D/Max2500VB+/Pc, 
Rigaku, Japan) with CuKα characteristic radiation (wavelength λ = 0.154 nm) at a voltage of 40 kV 
and a current of 50 mA. The scanning rate was 3° /min and the scanning scope of 2θ was from 2°  to 45°  
at room temperature (25 °C ). Thermogravimetric analysis (TGA) was carried out in a TA Q 50 system 
TGA. The samples were scanned from 0 to 800 °C  at a heating rate of 10 °C /min under flow of 
nitrogen. Differential scanning calorimetry (DSC) was performed using DSC Q1000V7.0 A universal 
V3.6C  TA  instrument,  with  heating  and  cooling  rates  of  10  °C   min
−1  was  used.  The  surface Int. J. Mol. Sci. 2012, 13  6112 
 
 
morphology  was  analyzed  by  scanning  electron  microscopy  (SEM)  JEOLJSM-6490LA).  The 
photoluminescence (PL) spectra were recorded on a Perkin-Elmer LS55 fluorescence spectrometer. 
UV-visible absorption  spectrum  was  measured  on an Agilent 8453 spectrophotometer (USA).  CD 
spectrum was recorded on a Jasco-J715 spectrometer in 1% acetic acid. The samples were contained in 
a 1 cm quartz cuvette. All spectra were taken in room temperature. 
3.3.1. Antimicrobial Activity Assay 
The chitosan-chromone derivative was tested for antimicrobial activity against Escherichia coli. 
Bacteria were grown in Luria-Bertani (LB) broth at 37 °C  for 24 h. Fifty microliters of growing culture 
were then streaked on Blood Agar Plate (BAP) containing the chitosan-chromone derivative in log 
dilution (0.0001, 0.001, 0.01, and 0.1%) and incubated at 37 °C  for 12 h. At the end of incubation, 
colony forming units (CFU) was measured for each group. 
3.3.2. Assay for Cellular Cytotoxicity, Proliferation and Viability 
Primary  mouse  embryonic  fibroblast  (MEF)  cells  were  isolated  from  the  ICR  mouse  strain  at  
15  days  post-coitum  (dpc),  and  cultured  in  Dulbecco’s  modified  Eagle’s  medium  (DMEM,  high 
glucose formulation; Gibco BRL, Grand Island, NY) supplemented with 10% (v/v) fetal bovine serum 
(Hyclone, Logan, UT), MEM nonessential amino acids (Gibco BRL), 50 µM 2-mercaptoethanol, and 
chitosan-chromone derivative (0, 20, 40, 80, 120, 800 g/mL) for seven days at 37 °C  in a humidified 
atmosphere of 5% CO2 in air. The cells were plated in 24 well plates at an initial seeding density of  
2–4 ×  10
4 cells/mL in triplicate and were evaluated for the rate of cellular toxicity and proliferation by 
counting the total number of cells every 24 h, as we described earlier [44]. The population doubling 
time was calculated with the equation Yend = Ystart ×  2(t/T), where T is the population doubling time, 
Ystart is the initial cell count, and Yend is the cell count at the end of culture period (t). The rate of cell 
proliferation (r) was calculated with the equation r = (logNH − logNI)/T2 − T1, where NH is number of 
cell harvested, NI is number of cells initially seeded, T1 is the time at seeding (h), and T2 is the time till 
harvesting (h). Viability of cells was evaluated based on the esterase enzyme activity and plasma 
membrane integrity upon FDA (3' 6'diacetyl  fluorescein diacetate) assay as described earlier [44]. 
Briefly, cells were washed in Dulbecco’s phosphate-buffered saline (DPBS) for 1 min followed by 
incubation with 2.5 μg/mL FDA stain for 1 min. Stained cells were then washed in PBS to remove the 
traces of the dye and observed under UV illumination of an epifluorescent microscope fitted with FITC 
filter set (excitation: 460–490 nm; emission; 515–550 nm; dichromatic: 505 nm). Live cells emitted 
green fluorescence while dead ones were non-fluorescent. Viability was calculated as the number of 
green cells/total number of cells × 100. All experiments were repeated three times. 
4. Conclusions 
Chitosan-chromone derivative xerogels have been prepared by converting the chitosan hydrogels by 
solvent exchange method. The formation of Schiff base (imine bond) was confirmed by FTIR, UV, 
and XRD. The TGA and DSC study show that the gels were thermally stable. The circular dichroism 
of the chromone derivative showed a broad negative signal with a decreased intensity and the PL Int. J. Mol. Sci. 2012, 13  6113 
 
 
spectrum displayed a red shift. The morphological study of the chitosan derivative has shown it has a 
porous structure. Microbiological screening demonstrated that the chitosan-chromone derivative has 
antimicrobial  activity.  The  assays  for  cell  proliferation  and  viability  showed  that  the  
chitosan-chromone derivative was non-cytotoxic. Thus, the chitosan-chromone derivative might be a 
very  promising  candidate  for  practical  applications  in  the  fields  of  biomedical,  tissue  engineering  
and biosensors. 
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